NCT07012993View on ClinicalTrials.gov

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Healthy VolunteerAlzheimer's Disease, Mild Cognitive Impairment, Other Forms of Dementia
Interventions
DRUG

18F-Florbetapir or 18F-Flutemetamol

Participants will be injected with 18F-Florbetapir or 18F-Flutemetamol and imaged for up to 3 hours on a PET scanner

Trial Locations (1)

07631

RECRUITING

Nuclear Imaging Institute, Englewood

All Listed Sponsors
lead

Akiva Mintz

OTHER